Alto Neuroscience ANRO Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Alto Neuroscience in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Alto Neuroscience's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Alto Neuroscience's operating income?
- Alto Neuroscience (ANRO) reported operating income of -$27.14M in Q1 2026.
- How has Alto Neuroscience's operating income changed year-over-year?
- Alto Neuroscience's operating income decreased by 73.1% year-over-year, from -$15.68M to -$27.14M.
- What is the long-term trend for Alto Neuroscience's operating income?
- Over 2 years (2023 to 2025), Alto Neuroscience's operating income has grown at a 32.5% compound annual growth rate (CAGR), from -$37.81M to -$66.36M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.